Pharmanutra
Researches and markets nutritional supplements & medical devices for all ages.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Established in 2003, PharmaNutra is a company specializing in the research, development, and marketing of nutritional supplements and medical devices. The firm emphasizes scientific innovation and manages the entire production process, from proprietary raw materials to finished goods. Through its in-house research centers and labs, it pioneers studies to create unique and effective products. The portfolio focuses on addressing nutritional deficiencies, such as minerals and vitamins, and supporting musculoskeletal and joint health for consumers of all ages.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-20 08:50 |
Regulatory News Service
Italian Roadshow 2025 - Paris
|
Italian | 5.4 MB | ||
| 2025-11-14 10:19 |
Regulatory News Service
INTERIM MANAGEMENT REPORT AS AT SEPTEMBER 30, 2025
|
Italian | 1.7 MB | ||
| 2025-11-14 10:17 |
Regulatory News Service
Resoconto intermedio di gestione al 30 settembre 2025
|
Italian | 1.7 MB | ||
| 2025-11-13 09:58 |
Regulatory News Service
Interim Management report as at September 30 2025
|
Italian | 1.8 MB | ||
| 2025-11-13 09:56 |
Regulatory News Service
Resoconto Intermedio di gestione al 30 settembre 2025
|
Italian | 1.7 MB | ||
| 2025-11-13 09:54 |
Regulatory News Service
Avviso deposito Rendiconto Intermedio di gestione al 30 settembre 2025 || Notic…
|
Italian | 225.3 KB | ||
| 2025-11-10 17:51 |
Earnings Release
PHARMANUTRA S.P.A.: BOARD OF DIRECTORS APPROVES THE INTERIM MANANGEMENT REPORT …
|
English | 338.9 KB | ||
| 2025-11-10 17:49 |
Earnings Release
PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTE…
|
Italian | 342.0 KB | ||
| 2025-11-04 11:34 |
Director's Dealing
ALLEGATO 3F - OTTOBRE 2025
|
Italian | 93.2 KB | ||
| 2025-10-20 08:00 |
Regulatory News Service
“SIDERAL® FORTE” PREMIATO COME MIGLIOR PRODOTTO NUTRACEUTICO || “SIDERAL® FORTE…
|
Italian | 278.3 KB | ||
| 2025-10-03 13:13 |
Transaction in Own Shares
Initiation of share buy-back program
|
English | 243.9 KB | ||
| 2025-10-03 13:12 |
Transaction in Own Shares
Avvio del programma di acquisti di azioni proprie
|
Italian | 232.8 KB | ||
| 2025-10-01 09:00 |
Investor Presentation
Eccellenze del Made in Italy | Presentazione
|
English | 5.0 MB | ||
| 2025-09-12 10:35 |
Interim Report
Half Year Financial Report 2025
|
English | 3.3 MB | ||
| 2025-09-12 10:34 |
Interim Report
Relazione finanziaria semestrale 2025
|
Italian | 3.4 MB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
